BTL Vanquish FDA Cleared for Circumferential Reduction of Abdomen Area

BTL Industries received FDA clearance of its BTL Vanquish device for circumferential reduction of the abdomen area. BTL Vanquish uses a panel array that emits selective RF energy with the largest spot size in the industry to treat the entire core in one application. Providing a clinically proven and safe treatment option without touching the patient’s skin, the breakthrough technology of BTL Vanquish surpasses earlier treatment options that require uncomfortable suction or labor-intensive application.

The system’s patented technology creates a high-frequency energy field that targets the thermal effects into the fat layer while protecting surrounding skin tissue. BTL Vanquish provides optimal aesthetic results across the entire abdominal area with maximum safety and comfort without surgery or downtime.

 “BTL Vanquish is truly a breakthrough technology. Published clinical studies show it permanently destroys unwanted fat for safe and measurable circumferential reduction of the abdominal area without the cost and inconvenience of surgery,” says David McDaniel, MD, a leading dermatologist and investigator of high-tech devices for non-invasive body contouring. “FDA clearance of Vanquish is a significant step forward in providing the newest treatment option for body slimming and shaping.”